Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 8, 2002, Pages 873-881

  Hui, Jason M ^a   Kench, James ^b   Farrell, Geoffrey C ^a   Lin, Rita ^a   Samarasinghe, Dev ^a   Liddle, Christopher ^a   Byth, Karen ^b   George, Jacob ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Body mass index; Cholesterol; Fatty liver; Fibrosis; Genotype; Hepatitis C; Insulin; Insulin resistance; Liver; Triglyceride

Indexed keywords

ALANINE AMINOTRANSFERASE; C PEPTIDE; CHOLESTEROL; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; FIBROGENESIS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOMEOSTASIS; HORMONE ACTION; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LABORATORY TEST; LIPID METABOLISM; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS GENOME;

EID: 0036381117     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02813.x     Document Type: Article

References (45)

1. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis. Hepatology 1992; 15: 572-4.
2. Lefkowitch JH, Schiff ER, Davis GL et al. Pathological diagnosis of chronic hepatitis C. A multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595-603.
3. Giannini E, Ceppa P, Botta Fet al. Steatosis and bile duct damage in chronic hepatitis C. Distribution and relationships in a group of northern Italian patients. Liver 1999; 19: 432-7.
4. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J. Hepatol. 1998; 29: 198-206.
5. Hourigan LF, Macdonald GA, Purdie Det al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-19.
6. Hwang SJ, Luo JC, Chu CW et al. Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation. J. Gastroenterol. Hepatol. 2001; 16: 190-5.
7. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997; 25: 735-9.
8. Rubbia-Brandt L, Quadri R, Abid K et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J. Hepatol. 2000; 33: 106-15.
9. Adinolfi LE, Utili R, Andreana A et al. Relationship between HCV genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur. J. Gastroenterol. Hepatol. 2000; 12: 299-304.
10. Fujie H, Yotsuyanngi H, Morija K et al. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J. Med. Virol. 1999; 59: 141-5.
11. Khan MH, Thomas L, Byth K et al. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J. Gastroenterol. Hepatol. 1998; 13: 419-26.
12. International Diabetes Institute. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Melbourne: Health Communications Australia, 2000.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
15. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
16. Petrides AS, Vogt C, Schulze-Berge D, Matthews Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994; 19: 616-27.
17. Merli M, Leonetti F, Riggio Oet al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology 1999; 30: 649-54.
18. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol. 1991; 13: 372-4.
19. Khan MH, Farrell GC, Byth Ket al. Which patients with hepatitis C develop liver complications? Hepatology 2000; 31: 513-20.
20. Shev S, Widell A, Foberg A et al. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 1995; 23: 253-7.
21. Fiore G, Fera G, Napoli N, Vella F, Schiraldi O. Liver steatosis and chronic hepatitis C. A spurious association? Eur. J. Gastroenterol. Hepatol. 1996; 8: 125-9.
22. Barba G, Harper F, Harada Tet al. Hepatitis C virus core protein shows a cytoplasmic localization and associated to cellular lipid storage droplets. Proc. Natl Acad. Sci. USA 1997; 94: 1200-5.
23. Sabile A, Perlemuter G, Bono Fet al. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 1999; 30: 1064-76.
24. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins. Med. Microbiol. Immunol. 1993; 182: 329-34.
25. Agnello V, Abel G, Elfahal M, Knight G, Zhang Q-X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 1999; 96: 12766-71.
26. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for stea-tosis in chronic hepatitis C. J. Hepatol. 2001; 34: 428-34.
27. Marceau P, Biron S, Hould FSet al. Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab. 1999; 84: 1513-17.
28. Moberly JB, Cole TG, Alpers DH, Schonfeld G. Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochim. Biophys. Acta 1990; 20: 70-80.
29. Pullinger CR, North JD, Teng BB et al. The apolipoprotein B gene is constitutively expressed in HepG2 cells: Regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J. Lipid Res. 1989; 30: 1065-77.
30. Dixon JL, Ginsberg H. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: Information obtained from cultured liver cells. J. Lipid Res. 1993; 34: 167-79.
31. Lo SY, Masiarz F, Hwang SB, Lai MM, Ou JH. Differential subcellular localization of hepatitis C virus core gene products. Virology 1995; 213: 455-61.
32. Schonfeld G. The hypobetalipoproteinemias. Annu. Rev. Nutr. 1995; 15: 123-35.
33. Tarugi P, Lonardo A, Ballarini G et al. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology 1996; 111: 1125-33.
34. Adinolfi LE, Gambardella M, Andreana A, Tripodi M-F, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-64.
35. Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 1995; 20: 127-30.
36. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis. A follow-up study of forty-two paitents for up to 21 years. Hepatology 1990; 11: 74-80.
37. Ostapowicz G, Watson KJR, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998; 27: 1730-5.
38. Pianko S, Blatt LM, Behling Cet al. The degree of elevation of ALT levels in chronic hepatitis C virus infection do indicate the degree of histological liver injury. J. Gastroenterol. Hepatol. 2000; 15 (Suppl.): J93 (Abstract).
39. Wong VS, Wright DGD, Palmer CR, Alexander GJM. Fibrosis and other histological features in chronic hepatitis C virus infection: A statistical model. J. Clin. Pathol. 1996; 49: 465-9.
40. Vaquer P, Canet R, Llompart A, Riera J, Obrador A, Gaya J. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994; 14: 265-9.
41. American Diabetes Association. Consensus development conference on insulin resistance. Diabetes. Care 1998; 21: 310-14.
42. Scharf JG, Knittel T, Dombrowski F et al. Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology 1998; 27: 1275-84.
43. Svegliati-Baroni G, Ridolfi F, Di Sario A et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways. Hepatology 1999; 29: 1743-51.
44. Augulo P, Keach J, Batts K, Lindor K. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
45. Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.